Maharaja Impex Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 8.00 M
- Company Age 18 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Satisfied Charges ₹ 2.50 Cr
- Revenue Growth -61.20%
- Profit Growth 35.21%
- Ebitda -39.65%
- Net Worth 1.86%
- Total Assets -50.09%
About Maharaja Impex
Maharaja Impex Private Limited (MIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 January 2007 and has a history of 18 years. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Juma Venkatesh, Samynathan Bhairavan, and Raj Venkatesh serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U05003TN2007PTC062138
-
Company No.
062138
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Maharaja Impex?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Juma Venkatesh
|
Director | 19-Feb-2007 | Current |
|
Samynathan Bhairavan
|
Director | 02-Nov-2016 | Current |
|
Raj Venkatesh
|
Additional Director | 05-Jan-2024 | Current |
Financial Performance of Maharaja Impex.
Maharaja Impex Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.2% decrease. The company also saw a substantial improvement in profitability, with a 35.21% increase in profit. The company's net worth moved up by a moderate rise of 1.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maharaja Impex?
Unlock access to Maharaja Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Glocare Labs Private LimitedRaj Venkatesh is a mutual person
-
Tablets Globalcare Private LimitedJuma Venkatesh is a mutual person
-
Global Pharma Healthcare Private LimitedJuma Venkatesh is a mutual person
-
Gp Pharmacare Private LimitedSamynathan Bhairavan is a mutual person
Charges (Loans)
₹20.00 M
₹25.00 M
Charges Breakdown by Lending Institutions
- Bank Of India : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2011 | Bank Of India | ₹2.00 Cr | Open |
| 29 Aug 2008 | Tamilnad Mercantile Bank Ltd | ₹2.50 Cr | Satisfied |
How Many Employees Work at Maharaja Impex?
Unlock and access historical data on people associated with Maharaja Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maharaja Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharaja Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
